Genesis Laboratories, Inc.
Wellington, CO
- UEI
- Q2RAMBFQRBV4
- CAGE
- 3A0Y6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 541380 Testing Laboratories and Services
- 541620 Environmental Consulting Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 561710 Exterminating and Pest Control Services
- 813312 Environment, Conservation and Wildlife Organizations
- SAM.gov registration date
- Physical address
- 10122 NE Frontage Rd, Wellington, CO 80549, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $620,310 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Inc. T.erry L. Schulze, Phd | Millstone, NJ | 541620 Environmental Consulting Services |
| Banfieldbio Inc. | Woodinville, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| ECO Laboratory Diagnostics, LLC | Acton, MA | 621511 Medical Laboratories |
| L2 Diagnostics LLC | Woodbridge, CT | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Crid | Yaounde, Centre | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Genesis Laboratories, Inc. is a for-profit, subchapter S corporation that provides products and services related to vector-borne disease research and prevention to the Centers for Disease Control and Prevention (CDC). As a registered corporate entity in SAM.gov since 2002, Genesis Laboratories has been awarded multiple federal contracts from the CDC to conduct field trials, provide bait products, and distribute mineral licks intended to control tick populations and Lyme disease incidence.
Through past prime federal contracts, Genesis Laboratories has provided fipronil-laced oral bait products and conducted related field trials in Colorado for the CDC's vector-borne disease program, as well as supplied mineral licks to systematically control black-legged ticks and reduce Lyme disease among white-tailed deer populations. The company was also awarded a CDC contract in 2020 to study methods of controlling immature Ixodes scapularis ticks in rodents. No set aside designations were associated with these awards, which ranged from $149,147 to $620,310 in value under purchase order, definitive, and Basic Ordering Agreement contract types.
SBA capabilities narrative
Ecotox testing for pesticide safety on wildlife. Wildlife diseases research, rodent and repellents r&d, formulation development, analytical chemistry, field studies, radio tags on birds, rodents, bats, turtles, pigs, cervids, and other wildlife.
Quick answers
Is Genesis Laboratories, Inc. registered in SAM.gov?
Yes. Genesis Laboratories, Inc.'s SAM.gov registration is active through April 13, 2027.
How much has Genesis Laboratories, Inc. received in federal contracts?
Federal contracts obligated $620,310 to Genesis Laboratories, Inc. in fiscal years 2023 through 2027.
What is Genesis Laboratories, Inc.'s most recent federal award?
Genesis Laboratories, Inc.'s most recent federal contract award is Field trial of fipronil-laced oral bait (75D30123C17159), from CDC Pittsburgh, on August 25, 2023.
On GovTribe
See Genesis Laboratories, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors